VANGUARD GROUP INC - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 1 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$101,000
-61.6%
292,603
-49.3%
0.00%–
Q4 2021$263,000
+17.9%
577,440
+80.7%
0.00%–
Q3 2021$223,000
-0.4%
319,614
+5.9%
0.00%–
Q2 2021$224,000
-22.0%
301,862
+4.6%
0.00%–
Q1 2021$287,000–288,661–0.00%–
 Download
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2022
NameSharesValueWeighting ↓
IMS Capital Management 20,146$7,0000.00%
VANGUARD GROUP INC 292,603$101,0000.00%
UBS Group AG 25,171$9,0000.00%
IFP Advisors, Inc 1$1,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 112$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 212$00.00%
NORTHERN TRUST CORP 70,536$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders